4.5 Review

Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection

Journal

JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 115, Issue 2, Pages 105-111

Publisher

JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.10R02CR

Keywords

interleukin-19; inflammatory bowel disease (IBD); colonic inflammation; macrophages; cytokine

Ask authors/readers for more resources

The cytokine, interleukin (IL)-19, is a member of the IL-10 family that includes IL-20, IL-22, IL-24, and IL-26. Recent studies have shown that IL-19 is produced by keratinocytes, epithelial cells, macrophages, and B-cells. Little is known about the exact biological role of IL-19 in immunological regulation, although there is an increasing body of data demonstrating that IL-19 is associated with the development of Th2 responses and the pathogenesis of psoriasis. In this review, I shall attempt to discuss current knowledge about the role of IL-19 on macrophages and the potential role in inflammatory bowel disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available